Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Zeneca discloses agents for pain associated with inflammation

Feb. 25, 1997

Immunex clones and describes target for RA

Feb. 21, 1997

Relaxin-like factor and relaxin analogues described

Feb. 21, 1997

Akzo reports peptides for specific tolerance therapy

Feb. 20, 1997

SKB prepares cytokine inhibitors

Feb. 19, 1997

University of California researchers report pseudopterosin derivatives

Feb. 19, 1997

Inhibitors of cell adhesion disclosed by Tanabe

Feb. 18, 1997

MGI Pharma seeks FDA approval of new indication for Salagen Tablets

Feb. 12, 1997

Arthritis gene therapy appears to hold promise

Feb. 12, 1997

Selective gelatinase inhibitor described by British Biotech

Feb. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.